82 related articles for article (PubMed ID: 22041280)
1. Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases.
Ohmuraya M; Yamamura K
Exp Anim; 2011; 60(5):433-44. PubMed ID: 22041280
[TBL] [Abstract][Full Text] [Related]
2. Rare hereditary cause of chronic pancreatitis in a young male: SPINK1 mutation.
Patel J; Madan A; Gammon A; Sossenheimer M; Samadder NJ
Pan Afr Med J; 2017; 28():110. PubMed ID: 29515728
[TBL] [Abstract][Full Text] [Related]
3. Pancreas-directed AAV8
Wang YC; Mao XT; Sun C; Wang YH; Zheng YZ; Xiong SH; Liu MY; Mao SH; Wang QW; Ma GX; Wu D; Li ZS; Chen JM; Zou WB; Liao Z
Gut; 2024 Jun; 73(7):1142-1155. PubMed ID: 38553043
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous Spink1 c.194+2T>C mutation promotes chronic pancreatitis after acute attack in mice.
Liu M; Ma L; An W; Yang Y; Liu J; Jiang H; Yuan J; Sun X; Zhu J; Yan M; Wang L; Li Z; Liao Z; Sun C
Pancreatology; 2024 May; ():. PubMed ID: 38763786
[TBL] [Abstract][Full Text] [Related]
5. SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization.
Suwa T; Kobayashi M; Shirai Y; Nam JM; Tabuchi Y; Takeda N; Akamatsu S; Ogawa O; Mizowaki T; Hammond EM; Harada H
JCI Insight; 2021 Nov; 6(21):. PubMed ID: 34747365
[TBL] [Abstract][Full Text] [Related]
6. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.
Chen F; Long Q; Fu D; Zhu D; Ji Y; Han L; Zhang B; Xu Q; Liu B; Li Y; Wu S; Yang C; Qian M; Xu J; Liu S; Cao L; Chin YE; Lam EW; Coppé JP; Sun Y
Nat Commun; 2018 Oct; 9(1):4315. PubMed ID: 30333494
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous Spink1 deficiency promotes trypsin-dependent chronic pancreatitis in mice.
Demcsák A; Sahin-Tóth M
Cell Mol Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38768901
[TBL] [Abstract][Full Text] [Related]
8. Serine protease inhibitor Kazal type 1 (SPINK1) as a prognostic marker in stage IV colon cancer patients receiving cetuximab based targeted therapy.
Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
J Clin Pathol; 2016 Apr; ():. PubMed ID: 27107100
[TBL] [Abstract][Full Text] [Related]
9. Combined SPINK1 mutations induce early-onset severe chronic pancreatitis in a child with severe obesity.
Abass MK; Al Shamsi A; Jan I; Masalawala MSY; Deeb A
Endocrinol Diabetes Metab Case Rep; 2022 Sep; 2022():. PubMed ID: 36053195
[TBL] [Abstract][Full Text] [Related]
10. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors.
Szmola R; Kukor Z; Sahin-Tóth M
J Biol Chem; 2003 Dec; 278(49):48580-9. PubMed ID: 14507909
[TBL] [Abstract][Full Text] [Related]
11. An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancer.
Manzar N; Khan UK; Goel A; Carskadon S; Gupta N; Palanisamy N; Ateeq B
iScience; 2024 Mar; 27(3):108794. PubMed ID: 38384854
[TBL] [Abstract][Full Text] [Related]
12. Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy.
Berke G; Sahin-Tóth M
Gut; 2024 May; ():. PubMed ID: 38754955
[No Abstract] [Full Text] [Related]
13. Emerging Roles of SPINK1 in Cancer.
Räsänen K; Itkonen O; Koistinen H; Stenman UH
Clin Chem; 2016 Mar; 62(3):449-57. PubMed ID: 26656134
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
Terry S; Nicolaiew N; Basset V; Semprez F; Soyeux P; Maillé P; Vacherot F; Ploussard G; Londoño-Vallejo A; de la Taille A; Allory Y
Cancer; 2015 May; 121(9):1422-30. PubMed ID: 25639219
[TBL] [Abstract][Full Text] [Related]
15. Molecular foundations for personalized therapy in prostate cancer.
Fisher KW; Montironi R; Lopez Beltran A; Moch H; Wang L; Scarpelli M; Williamson SR; Koch MO; Cheng L
Curr Drug Targets; 2015; 16(2):103-14. PubMed ID: 25547910
[TBL] [Abstract][Full Text] [Related]
16. SPINK1 protein expression and prostate cancer progression.
Flavin R; Pettersson A; Hendrickson WK; Fiorentino M; Finn S; Kunz L; Judson GL; Lis R; Bailey D; Fiore C; Nuttall E; Martin NE; Stack E; Penney KL; Rider JR; Sinnott J; Sweeney C; Sesso HD; Fall K; Giovannucci E; Kantoff P; Stampfer M; Loda M; Mucci LA
Clin Cancer Res; 2014 Sep; 20(18):4904-11. PubMed ID: 24687926
[TBL] [Abstract][Full Text] [Related]
17. Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.
Wang C; Wang L; Su B; Lu N; Song J; Yang X; Fu W; Tan W; Han B
Prostate; 2014 May; 74(7):689-701. PubMed ID: 24619958
[TBL] [Abstract][Full Text] [Related]
18. Role of Intrapancreatic SPINK1/Spink3 Expression in the Development of Pancreatitis.
Ohmuraya M; Sugano A; Hirota M; Takaoka Y; Yamamura K
Front Physiol; 2012; 3():126. PubMed ID: 22586407
[TBL] [Abstract][Full Text] [Related]
19. New insights into the pathogenesis of pancreatitis.
Sah RP; Dawra RK; Saluja AK
Curr Opin Gastroenterol; 2013 Sep; 29(5):523-30. PubMed ID: 23892538
[TBL] [Abstract][Full Text] [Related]
20. Functional Roles of SPINK1 in Cancers.
Lin TC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
